Jun Tao

3.9k total citations · 2 hit papers
97 papers, 3.0k citations indexed

About

Jun Tao is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Jun Tao has authored 97 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 29 papers in Cancer Research and 23 papers in Surgery. Recurrent topics in Jun Tao's work include Renal Transplantation Outcomes and Treatments (22 papers), MicroRNA in disease regulation (16 papers) and Cancer-related molecular mechanisms research (16 papers). Jun Tao is often cited by papers focused on Renal Transplantation Outcomes and Treatments (22 papers), MicroRNA in disease regulation (16 papers) and Cancer-related molecular mechanisms research (16 papers). Jun Tao collaborates with scholars based in China, United States and Macao. Jun Tao's co-authors include Pengchao Li, Xiao Yang, Haiwei Yang, Qiang Lü, Wei Zhang, Wenbo Yuan, Min Gu, Jie Han, Jingzi Wang and Chengdi Yang and has published in prestigious journals such as Nature Communications, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Jun Tao

92 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression

2018 398 citations Chengdi Yang, Wenbo Yuan et al. Molecular Cancer profile →
The role of the HIF‐1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer

2021 205 citations Jingzi Wang, Jie Han et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jun Tao China	26	2.1k	1.7k	410	309	260	97	3.0k
Jianxin Qiu China	22	1.2k 0.6×	964 0.6×	307 0.7×	134 0.4×	182 0.7×	65	2.0k
Xiaoshun He China	23	1.6k 0.8×	982 0.6×	511 1.2×	221 0.7×	339 1.3×	115	2.6k
Shujun Li China	30	2.4k 1.2×	1.9k 1.1×	237 0.6×	342 1.1×	322 1.2×	134	3.2k
Giulia Romano United States	32	3.0k 1.4×	2.6k 1.5×	185 0.5×	252 0.8×	315 1.2×	63	3.8k
Randolph A. Hennigar United States	23	1.2k 0.6×	729 0.4×	382 0.9×	527 1.7×	199 0.8×	49	2.5k
Noritoshi Kato Japan	16	1.7k 0.8×	1.1k 0.6×	127 0.3×	205 0.7×	135 0.5×	50	2.3k
Jeremias Wohlschlaeger Germany	30	1.1k 0.5×	459 0.3×	769 1.9×	579 1.9×	646 2.5×	114	2.8k
Yen‐Ming Hsu United States	24	1.1k 0.5×	799 0.5×	256 0.6×	136 0.4×	377 1.4×	36	3.1k
Donge Tang China	22	1.0k 0.5×	395 0.2×	117 0.3×	146 0.5×	198 0.8×	149	1.8k
Revati Shreeniwas United States	16	1.2k 0.6×	688 0.4×	292 0.7×	198 0.6×	179 0.7×	18	2.3k

Countries citing papers authored by Jun Tao

Since Specialization

Citations

This map shows the geographic impact of Jun Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Tao more than expected).

Fields of papers citing papers by Jun Tao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Tao. The network helps show where Jun Tao may publish in the future.

Co-authorship network of co-authors of Jun Tao

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Tao. A scholar is included among the top collaborators of Jun Tao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Tao. Jun Tao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Jianjian, Qingya Shen, Shuang Fei, et al.. (2025). Dual Phosphorylation of STAT1 at Y701/S727 by TNFα Drives AIM2-Mediated PANoptosis of Renal Tubular Epithelial Cells and Fibrotic Progression in Renal Allografts. International Journal of Biological Sciences. 22(2). 582–600.

Sun, Li, Fei Shuang, Hao Chen, et al.. (2024). Long-term outcomes in rapamycin on renal allograft function: a 30-year follow-up from a single-center experience. BMC Nephrology. 25(1). 311–311.

Ni, Bing, Hai Zhou, Ming Zheng, et al.. (2024). IL-34 attenuates acute T cell-mediated rejection following renal transplantation by upregulating M2 macrophages polarization. Heliyon. 10(1). e24028–e24028. 7 indexed citations

Duan, Jinhong, Jun Tao, Wen Wang, et al.. (2023). Oxidized LDL Regulates Endothelin-1 and Oxidative Stress in Vascular Endothelial Cells: Role of Extracellular Regulated Kinase1/2 (ERK1/2). 1 indexed citations

Chen, Zhijun, et al.. (2023). ITGB1 alleviates osteoarthritis by inhibiting cartilage inflammation and apoptosis via activating cAMP pathway. Journal of Orthopaedic Surgery and Research. 18(1). 849–849. 11 indexed citations

Suo, Chuanjian, Jun Tao, Zijie Wang, et al.. (2022). Everolimus Alleviates Renal Allograft Interstitial Fibrosis by Inhibiting Epithelial-to-Mesenchymal Transition Not Only via Inducing Autophagy but Also via Stabilizing IκB-α. Frontiers in Immunology. 12. 753412–753412. 13 indexed citations

Wu, Qikai, Baorui Yuan, Qiang Cao, et al.. (2022). The application value of multi-parameter cystoscope in improving the accuracy of preoperative bladder cancer grading. BMC Urology. 22(1). 111–111. 2 indexed citations

Chen, Yuanli, Jun Tao, Pei‐Ji Zhao, et al.. (2019). Adiponectin receptor PAQR-2 signaling senses low temperature to promote C. elegans longevity by regulating autophagy. Nature Communications. 10(1). 2602–2602. 67 indexed citations

Yang, Chengdi, Wenbo Yuan, Xiao Yang, et al.. (2018). Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression. Molecular Cancer. 17(1). 19–19. 398 indexed citations breakdown →

10.

Li, Peng, Xiao Yang, Yidong Cheng, et al.. (2017). MicroRNA-218 Increases the Sensitivity of Bladder Cancer to Cisplatin by Targeting Glut1. Cellular Physiology and Biochemistry. 41(3). 921–932. 81 indexed citations

11.

Wu, Deyao, Xiaobing Niu, Jun Tao, et al.. (2017). MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2. Oncology Reports. 37(6). 3502–3508. 45 indexed citations

12.

Zhang, Yu‐Dong, et al.. (2016). Feasibility of triphasic CT with a modified two-point Patlak plot to determine spit kidney glomerular filtration rate in clinical practice. Abdominal Radiology. 42(1). 226–235. 3 indexed citations

13.

Huang, Zhengkai, Bian Wu, Jun Tao, et al.. (2015). Association between Angiotensin I-Converting Enzyme Insertion/Deletion Polymorphism and Prognosis of Kidney Transplantation: A Meta-Analysis. PLoS ONE. 10(5). e0127320–e0127320. 6 indexed citations

14.

Lü, Qiang, Yidong Cheng, Xiaheng Deng, et al.. (2015). Urine microRNAs as biomarkers for bladder cancer: a diagnostic meta-analysis. OncoTargets and Therapy. 8. 2089–2089. 12 indexed citations

15.

Li, Pengchao, Jun Tao, Xiao Yang, et al.. (2015). Serum metabolomic analysis of human upper urinary tract urothelial carcinoma. Tumor Biology. 36(10). 7531–7537. 9 indexed citations

16.

Liu, Chao, Jun Wang, Zhijian Han, et al.. (2014). Effect of rapamycin on formation of atherosclerosis induced by AGEs in renal transplantation recipients and mechanism. 35(4). 211–215. 1 indexed citations

17.

Yang, Xiao, Pengchao Li, Jun Tao, et al.. (2014). Association betweenNFKB1−94ins/del ATTG Promoter Polymorphism and Cancer Susceptibility: An Updated Meta-Analysis. International Journal of Genomics. 2014. 1–8. 26 indexed citations

18.

Yang, Xiao, Pengchao Li, Chao Qin, et al.. (2013). TSP-1-1223 A/G Polymorphism as a Potential Predictor of the Recurrence Risk of Bladder Cancer in a Chinese Population. International Journal of Genomics. 2013. 1–9. 2 indexed citations

19.

Wu, Deyao, Jun Tao, Jingjing Ding, et al.. (2012). Interleukin-11, an interleukin-6-like cytokine, is a promising predictor for bladder cancer prognosis. Molecular Medicine Reports. 7(2). 684–688. 12 indexed citations

20.

Xu, Bin, Ning Wang, Xuhui Wang, et al.. (2011). MiR‐146a suppresses tumor growth and progression by targeting EGFR pathway and in a p‐ERK‐dependent manner in castration‐resistant prostate cancer. The Prostate. 72(11). 1171–1178. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact